For: | Triantafillidis JK, Konstadoulakis MM, Papalois AE. Immunotherapy of gastric cancer: Present status and future perspectives. World J Gastroenterol 2024; 30(8): 779-793 [PMID: 38516237 DOI: 10.3748/wjg.v30.i8.779] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i8/779.htm |
Number | Citing Articles |
1 |
Dong Luo, Yunmei Liu, Zhengmao Lu, Lei Huang. Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01075-y
|
2 |
Vasile Bintintan, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Gabriel Samasca. Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update. Diagnostics 2024; 14(12): 1247 doi: 10.3390/diagnostics14121247
|
3 |
Chandana Yesudas, Yoga Soundarya Mohanraj, Jayaprakash Senthil, Ponmathi PanneerPandian, Krishnaveni Ganesan, Anisha Marina Mariyanayagam, Srutimanjari Parida, Illakkiam Devaraj, Ganesan Kumaresan. Identification of molecular therapeutic features of the homeopathy medicine Thuja by genome-wide expression profiling. Pharmacological Research - Modern Chinese Medicine 2025; : 100596 doi: 10.1016/j.prmcm.2025.100596
|
4 |
Jane E. Rogers, Qiong Gan, Rebecca E. Waters, Ashley A. Horak, Jaffer A. Ajani. Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art. Expert Opinion on Biological Therapy 2024; 24(10): 1005 doi: 10.1080/14712598.2024.2401622
|
5 |
Zijie Wei, Ziqian Kou, Yun Luo, Yu Cheng. DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer. Medicine 2025; 104(7): e41578 doi: 10.1097/MD.0000000000041578
|